Cargando…

Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study

BACKGROUND: Abacavir (ABC) and Zidovudine (AZT) based regimens are the preferred first line nucleoside reverse transcriptase (NRTIs) backbones being widely utilized for managing HIV infection in children. However, there is a dearth of data regarding the clinical outcomes and associated risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Mega, Teshale Ayele, Usamo, Firehiwot Belayneh, Negera, Getandale Zeleke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053120/
https://www.ncbi.nlm.nih.gov/pubmed/32126978
http://dx.doi.org/10.1186/s12887-020-1995-4
_version_ 1783502978418737152
author Mega, Teshale Ayele
Usamo, Firehiwot Belayneh
Negera, Getandale Zeleke
author_facet Mega, Teshale Ayele
Usamo, Firehiwot Belayneh
Negera, Getandale Zeleke
author_sort Mega, Teshale Ayele
collection PubMed
description BACKGROUND: Abacavir (ABC) and Zidovudine (AZT) based regimens are the preferred first line nucleoside reverse transcriptase (NRTIs) backbones being widely utilized for managing HIV infection in children. However, there is a dearth of data regarding the clinical outcomes and associated risk factors in Ethiopia. We compared the proportion of mortality and the rate of occurrence of Opportunistic Infections (OIs) with ABC versus AZT -based regimens in a cohort of HIV-infected children. METHODS: A 42 months retrospective cohort study was conducted. A total of 179 records were reviewed by including data from October 2014 to April 2017. Data were collected on socio-demographic, clinical characteristics of patients and drug related variables. Data were analyzed using STATA13.1. Kaplan-Meier and Cox regression were used to compare survival experience and identify independent predictors. Propensity score matching analysis was conducted to elucidate the average treatment effects of each regimen over OIs. RESULT: Of 179 patients, 98 (54.7%) were females. The mean (+SD) age of the study subjects was 6.53 ± 2.83 years. Through 42 months analysis, a total of 4 patients (1 (1.14%) from ABC group and 3 (3.3%) from AZT group (p = 0.339)) were died. The incidence of opportunistic infections attributed to ABC group was 8.77/100,000 person years (py) and that of AZT was 6.9/100,000py. The incidence rate ratio (IRR) for OIs was (IRR = 0.87, 95% CI [0.49–1.53] (p = 0.304). Baseline CD4 count (AHR = 0.99, 95% CI [0.98–0.99]), Severe acute malnutrition (AHR = 15.92, 95% CI [5.34–47.50]), and exposure to tuberculosis treatment (AHR = 2.93, 95% CI [1.39–6.17]) were the independent predictors for the development of OIs. CONCLUSION: ABC and AZT based ART regimens seem to have comparable survival benefit among HIV-infected children in Ethiopia. Therefore, both regimens might be used as an alternative in resource limited settings.
format Online
Article
Text
id pubmed-7053120
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70531202020-03-10 Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study Mega, Teshale Ayele Usamo, Firehiwot Belayneh Negera, Getandale Zeleke BMC Pediatr Research Article BACKGROUND: Abacavir (ABC) and Zidovudine (AZT) based regimens are the preferred first line nucleoside reverse transcriptase (NRTIs) backbones being widely utilized for managing HIV infection in children. However, there is a dearth of data regarding the clinical outcomes and associated risk factors in Ethiopia. We compared the proportion of mortality and the rate of occurrence of Opportunistic Infections (OIs) with ABC versus AZT -based regimens in a cohort of HIV-infected children. METHODS: A 42 months retrospective cohort study was conducted. A total of 179 records were reviewed by including data from October 2014 to April 2017. Data were collected on socio-demographic, clinical characteristics of patients and drug related variables. Data were analyzed using STATA13.1. Kaplan-Meier and Cox regression were used to compare survival experience and identify independent predictors. Propensity score matching analysis was conducted to elucidate the average treatment effects of each regimen over OIs. RESULT: Of 179 patients, 98 (54.7%) were females. The mean (+SD) age of the study subjects was 6.53 ± 2.83 years. Through 42 months analysis, a total of 4 patients (1 (1.14%) from ABC group and 3 (3.3%) from AZT group (p = 0.339)) were died. The incidence of opportunistic infections attributed to ABC group was 8.77/100,000 person years (py) and that of AZT was 6.9/100,000py. The incidence rate ratio (IRR) for OIs was (IRR = 0.87, 95% CI [0.49–1.53] (p = 0.304). Baseline CD4 count (AHR = 0.99, 95% CI [0.98–0.99]), Severe acute malnutrition (AHR = 15.92, 95% CI [5.34–47.50]), and exposure to tuberculosis treatment (AHR = 2.93, 95% CI [1.39–6.17]) were the independent predictors for the development of OIs. CONCLUSION: ABC and AZT based ART regimens seem to have comparable survival benefit among HIV-infected children in Ethiopia. Therefore, both regimens might be used as an alternative in resource limited settings. BioMed Central 2020-03-03 /pmc/articles/PMC7053120/ /pubmed/32126978 http://dx.doi.org/10.1186/s12887-020-1995-4 Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Mega, Teshale Ayele
Usamo, Firehiwot Belayneh
Negera, Getandale Zeleke
Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
title Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
title_full Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
title_fullStr Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
title_full_unstemmed Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
title_short Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
title_sort abacavir versus zidovudine-based regimens for treatment of hiv-infected children in resource limited settings: a retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053120/
https://www.ncbi.nlm.nih.gov/pubmed/32126978
http://dx.doi.org/10.1186/s12887-020-1995-4
work_keys_str_mv AT megateshaleayele abacavirversuszidovudinebasedregimensfortreatmentofhivinfectedchildreninresourcelimitedsettingsaretrospectivecohortstudy
AT usamofirehiwotbelayneh abacavirversuszidovudinebasedregimensfortreatmentofhivinfectedchildreninresourcelimitedsettingsaretrospectivecohortstudy
AT negeragetandalezeleke abacavirversuszidovudinebasedregimensfortreatmentofhivinfectedchildreninresourcelimitedsettingsaretrospectivecohortstudy